Relay Therapeutics is trading at $20.03, up 7.26%, as broad-market strength likely contributed to its November 9 move.

  • The S&P 500 rose 2.00%, the Nasdaq Composite 2.46%, and the Dow 1.66%.
  • No clear company-specific announcement explaining the move was found. Recent company updates include Q3 results and clinical-program progress reported November 4; confidence is medium because no direct stock-specific explanation was confirmed.